Stock stagnation prompts a 16% pay cut for AstraZeneca CEO Pascal Soriot despite strong sales sheet
Despite AstraZeneca’s revenue growing 18% in 2024, the pay package for CEO Pascal Soriot dipped 16% from 17.4 million pounds sterling ($21.9 million) in 2023 to 14.7 million pounds ($18.5 million), according to the company’s annual report.
Despite AstraZeneca’s revenue growing 18% in 2024, the pay package for CEO Pascal Soriot dipped 16% from 17.4 million pounds sterling ($21.9 million) in 2023 to 14.7 million pounds ($18.5 million), according to the company’s annual report.
